*	OR T1 T2
R1	Has_value Arg1:T4 Arg2:T3	
*	OR T6 T7
R2	AND Arg1:T5 Arg2:T6	
R3	Has_multiplier Arg1:T11 Arg2:T9	
R4	AND Arg1:T10 Arg2:T11	
*	OR T5 T10
R5	Has_value Arg1:T12 Arg2:T13	
R6	AND Arg1:T12 Arg2:T14	
R7	Has_multiplier Arg1:T16 Arg2:T15	
R8	Has_multiplier Arg1:T19 Arg2:T17	
R9	Has_temporal Arg1:T19 Arg2:T18	
R10	Has_temporal Arg1:T20 Arg2:T21	
T1	Person 0 4	Male
T2	Person 8 14	female
T3	Value 15 24	= 2 years
T4	Person 28 31	age
T5	Condition 39 58	sickle cell disease
T6	Procedure 73 91	Hb electrophoresis
T7	Procedure 95 114	more specific tests
T10	Condition 119 154	other conditions with iron overload
T9	Multiplier 160 168	repeated
T11	Procedure 169 187	blood transfusions
T12	Measurement 230 242	Baseline LIC
T13	Value 243 250	>7 mg/g
T14	Procedure 267 270	MRI
T15	Multiplier 301 316	no less than 20
T16	Procedure 317 337	transfusions of RBCs
T17	Multiplier 367 377;390 398	at least 1 per year
T18	Temporal 399 418	in the last 2 years
T19	Procedure 378 389	transfusion
T20	Condition 431 472	expected to have a continuing requirement
T21	Temporal 509 541	during the duration of the trial
